What are products of Aurobindo Pharma?
Aurobindo Pharma Ltd. – Product List
- Tripcut. Advertisement. Cefoperazone Sodium Injection.
- Diceta. Diltiazem.
- Pryde MPS (10+125) Doxazosin.
- Viranz. Famotidine.
- Brox. Lamivudine.
- Neivex. Nevirapine.
- PLX -400. Roxithromycin.
What is Aurobindo Pharma known for?
In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
What is the target of Aurobindo Pharma?
NSE 0.47 %. price can reach defined target. Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 32411.19 Crore) operating in Pharmaceuticals sector….Most Searched Stocks.
|Tata Motors Share Price||416.35|
|03:59 PM | 06 Jul 2022||2.45 (0.59%)|
Is Aurobindo Pharma a good company?
Aurobindo Pharma has an overall rating of 3.6 out of 5, based on over 394 reviews left anonymously by employees. 71% of employees would recommend working at Aurobindo Pharma to a friend and 63% have a positive outlook for the business. This rating has decreased by -6% over the last 12 months.
What type of drug is Aurobindo?
Aurobindo’s product is the generic of Genus Lifesciences’ Oxycodone hydrochloride oral solution, 5 mg/5 mL (1 mg/mL) and 100 mg/5 mL (20 mg/mL). Oxycodone hydrochloride oral solution has a market value of about $33 million for the 12 months ending December 2019, according to IQVIA.
What kind of drug is Aurobindo?
Will Auropharma go up?
Based on our forecasts, a long-term increase is expected, the “AUROPHARMA” stock price prognosis for 2027-07-02 is 659.106 INR. With a 5-year investment, the revenue is expected to be around +20.59%. Your current $100 investment may be up to $120.59 in 2027. Get It Now!
Is Laurus Labs a good buy?
Jefferies Group has buy call on Laurus Labs with a target price of Rs 691. The current market price of Laurus Labs is Rs 592.6. Laurus Labs, incorporated in the year 2005, is a Mid Cap company (having a market cap of Rs 31970.19 Crore) operating in Pharmaceuticals sector.
Are Aurobindo drugs safe?
India’s Aurobindo Pharma has been one of the culprits found manufacturing the high blood pressure medicine valsartan with high levels of impurities that carry a risk of cancer. Now the FDA has savaged it in a warning letter for missteps that paved the pathway to the mess.
What is the rank of Aurobindo Pharma in India?
Aurobindo Pharma is the 2nd largest pharmaceuticals company in India.
Is Aurobindo FDA approved?
The FDA slapped Aurobindo Pharma, an Indian drugmaker, with a warning letter for failing to adequately investigate batch failures of active pharmaceutical ingredients and not evaluating the possible effect of changes on the intermediates and APIs manufactured at the site.
Who manufactures Aurobindo?
Amgen acquired the company in 2012 and renamed it Gensenta in 2020. The company has two manufacturing facilities located in Yenibosna, Turkey, and Istanbul that produce finished dosage forms, antibiotics, cancer treatments and other drugs. The sale is pending approval from the Turkish Competition Authority.
Should I buy Aurobindo Pharma shares?
Recent correction in the stock price (~27% in last 3 months) provides valuation comfort. Upgrade to BUY from Add with a revised target price of Rs649/share. Promoters held 51.83 per cent stake in the company as of 31-Mar-2022, while FIIs owned 22.48 per cent, DIIs 15.82 per cent.
Is Aurobindo Pharma Debt Free?
In fiscal year 2021, Aurobindo Pharma Limited had -0.04 debt to equity ratio, which was a decrease from the previous financial year. The pharmaceutical company recorded a revenue of over 247.74 billion Indian rupees in financial year 2021.
What is the future of Laurus Labs?
Laurus Labs Ltd. quote is equal to 487.400 INR at 2022-07-10. Based on our forecasts, a long-term increase is expected, the “Laurus Labs Ltd” stock price prognosis for 2027-07-02 is 775.622 INR. With a 5-year investment, the revenue is expected to be around +59.13%.
What is the problem with Aurobindo Pharma?
Last month, the pharmaceutical firm had recalled Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12. The USFDA stated that Aurobindo Pharma USA Inc, a unit of the Hyderabad-based drug major, is recalling 4,33,809 vials of Cyanocobalamin injection for being a “Subpotent Drug”.